Global Pregabalin Market Insights and Forecast to 2026

1 Study Coverage

• 1.1 Pregabalin Product Introduction
• 1.2 Market Segments
• 1.3 Key Pregabalin Manufacturers Covered: Ranking by Revenue
• 1.4 Market by Type
  • 1.4.1 Global Pregabalin Market Size Growth Rate by Type
  • 1.4.2 0.997
  • 1.4.3 0.998
  • 1.4.4 0.999
  • 1.4.5 Others
• 1.5 Market by Application
  • 1.5.1 Global Pregabalin Market Size Growth Rate by Application
  • 1.5.2 Tablet Product
  • 1.5.3 Capsule Product
  • 1.5.4 Oral Solution Product
• 1.6 Study Objectives
• 1.7 Years Considered

2 Executive Summary

• 2.1 Global Pregabalin Market Size, Estimates and Forecasts
  • 2.1.1 Global Pregabalin Revenue 2015-2026
  • 2.1.2 Global Pregabalin Sales 2015-2026
• 2.2 Global Pregabalin, Market Size by Producing Regions: 2015 VS 2020 VS 2026
  • 2.2.1 Global Pregabalin Retrospective Market Scenario in Sales by Region: 2015-2020
  • 2.2.2 Global Pregabalin Retrospective Market Scenario in Revenue by Region: 2015-2020

3 Global Pregabalin Competitor Landscape by Players

• 3.1 Pregabalin Sales by Manufacturers
  • 3.1.1 Pregabalin Sales by Manufacturers (2015-2020)
  • 3.1.2 Pregabalin Sales Market Share by Manufacturers (2015-2020)
• 3.2 Pregabalin Revenue by Manufacturers
  • 3.2.1 Pregabalin Revenue by Manufacturers (2015-2020)
  • 3.2.2 Pregabalin Revenue Share by Manufacturers (2015-2020)
  • 3.2.3 Global Pregabalin Market Concentration Ratio (CR5 and HHI) (2015-2020)
  • 3.2.4 Global Top 10 and Top 5 Companies by Pregabalin Revenue in 2019
  • 3.2.5 Global Pregabalin Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
• 3.3 Pregabalin Price by Manufacturers
• 3.4 Pregabalin Manufacturing Base Distribution, Product Types
  • 3.4.1 Pregabalin Manufacturers Manufacturing Base Distribution, Headquarters
  • 3.4.2 Manufacturers Pregabalin Product Type
  • 3.4.3 Date of International Manufacturers Enter into Pregabalin Market
• 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)

• 4.1 Global Pregabalin Market Size by Type (2015-2020)
  • 4.1.1 Global Pregabalin Sales by Type (2015-2020)
  • 4.1.2 Global Pregabalin Revenue by Type (2015-2020)
  • 4.1.3 Pregabalin Average Selling Price (ASP) by Type (2015-2026)
• 4.2 Global Pregabalin Market Size Forecast by Type (2021-2026)
  • 4.2.1 Global Pregabalin Sales Forecast by Type (2021-2026)
  • 4.2.2 Global Pregabalin Revenue Forecast by Type (2021-2026)
  • 4.2.3 Pregabalin Average Selling Price (ASP) Forecast by Type (2021-2026)
• 4.3 Global Pregabalin Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End

5 Market Size by Application (2015-2026)

• 5.1 Global Pregabalin Market Size by Application (2015-2020)
  • 5.1.1 Global Pregabalin Sales by Application (2015-2020)
  • 5.1.2 Global Pregabalin Revenue by Application (2015-2020)
  • 5.1.3 Pregabalin Price by Application (2015-2020)
• 5.2 Pregabalin Market Size Forecast by Application (2021-2026)
  • 5.2.1 Global Pregabalin Sales Forecast by Application (2021-2026)
  • 5.2.2 Global Pregabalin Revenue Forecast by Application (2021-2026)
  • 5.2.3 Global Pregabalin Price Forecast by Application (2021-2026)

6 North America

• 6.1 North America Pregabalin by Country
  • 6.1.1 North America Pregabalin Sales by Country
  • 6.1.2 North America Pregabalin Revenue by Country
  • 6.1.3 U.S.
  • 6.1.4 Canada
• 6.2 North America Pregabalin Market Facts & Figures by Type
• 6.3 North America Pregabalin Market Facts & Figures by Application

7 Europe

• 7.1 Europe Pregabalin by Country
  • 7.1.1 Europe Pregabalin Sales by Country
  • 7.1.2 Europe Pregabalin Revenue by Country
  • 7.1.3 Germany
  • 7.1.4 France
  • 7.1.5 U.K.
  • 7.1.6 Italy
  • 7.1.7 Russia
• 7.2 Europe Pregabalin Market Facts & Figures by Type
• 7.3 Europe Pregabalin Market Facts & Figures by Application

8 Asia Pacific

• 8.1 Asia Pacific Pregabalin by Region
  • 8.1.1 Asia Pacific Pregabalin Sales by Region
  • 8.1.2 Asia Pacific Pregabalin Revenue by Region
  • 8.1.3 China
  • 8.1.4 Japan
  • 8.1.5 South Korea
  • 8.1.6 India
  • 8.1.7 Australia
  • 8.1.8 Taiwan
  • 8.1.9 Indonesia
  • 8.1.10 Thailand
  • 8.1.11 Malaysia
  • 8.1.12 Philippines
  • 8.1.13 Vietnam
• 8.2 Asia Pacific Pregabalin Market Facts & Figures by Type
• 8.3 Asia Pacific Pregabalin Market Facts & Figures by Application

9 Latin America

• 9.1 Latin America Pregabalin by Country
  • 9.1.1 Latin America Pregabalin Sales by Country
  • 9.1.2 Latin America Pregabalin Revenue by Country
  • 9.1.3 Mexico
  • 9.1.4 Brazil
  • 9.1.5 Argentina
• 9.2 Central & South America Pregabalin Market Facts & Figures by Type
• 9.3 Central & South America Pregabalin Market Facts & Figures by Application

10 Middle East and Africa

• 10.1 Middle East and Africa Pregabalin by Country
  • 10.1.1 Middle East and Africa Pregabalin Sales by Country
  • 10.1.2 Middle East and Africa Pregabalin Revenue by Country
  • 10.1.3 Turkey
  • 10.1.4 Saudi Arabia
  • 10.1.5 U.A.E
• 10.2 Middle East and Africa Pregabalin Market Facts & Figures by Type
• 10.3 Middle East and Africa Pregabalin Market Facts & Figures by Application

11 Company Profiles

• 11.1 ZCL Chemicals Ltd.
  • 11.1.1 ZCL Chemicals Ltd. Corporation Information
  • 11.1.2 ZCL Chemicals Ltd. Description and Business Overview
  • 11.1.3 ZCL Chemicals Ltd. Sales, Revenue and Gross Margin (2015-2020)
  • 11.1.4 ZCL Chemicals Ltd. Pregabalin Products Offered
  • 11.1.5 ZCL Chemicals Ltd. Related Developments
• 11.2 Olon S.p.A.
  • 11.2.1 Olon S.p.A. Corporation Information
  • 11.2.2 Olon S.p.A. Description and Business Overview
  • 11.2.3 Olon S.p.A. Sales, Revenue and Gross Margin (2015-2020)
  • 11.2.4 Olon S.p.A. Pregabalin Products Offered
  • 11.2.5 Olon S.p.A. Related Developments
• 11.3 AASraw Biochemical Technology Co., Ltd.
  • 11.3.1 AASraw Biochemical Technology Co., Ltd. Corporation Information
  • 11.3.2 AASraw Biochemical Technology Co., Ltd. Description and Business Overview
  • 11.3.3 AASraw Biochemical Technology Co., Ltd. Sales, Revenue and Gross Margin (2015-2020)
  • 11.3.4 AASraw Biochemical Technology Co., Ltd. Pregabalin Products Offered
  • 11.3.5 AASraw Biochemical Technology Co., Ltd. Related Developments
• 11.4 Changzhou Pharmaceutical Factory (CPF)
  • 11.4.1 Changzhou Pharmaceutical Factory (CPF) Corporation Information
  • 11.4.2 Changzhou Pharmaceutical Factory (CPF) Description and Business Overview
  • 11.4.3 Changzhou Pharmaceutical Factory (CPF) Sales, Revenue and Gross Margin (2015-2020)
  • 11.4.4 Changzhou Pharmaceutical Factory (CPF) Pregabalin Products Offered
  • 11.4.5 Changzhou Pharmaceutical Factory (CPF) Related Developments
• 11.5 Almelo Pvt. Ltd.
  • 11.5.1 Almelo Pvt. Ltd. Corporation Information
  • 11.5.2 Almelo Pvt. Ltd. Description and Business Overview
  • 11.5.3 Almelo Pvt. Ltd. Sales, Revenue and Gross Margin (2015-2020)
  • 11.5.4 Almelo Pvt. Ltd. Pregabalin Products Offered
  • 11.5.5 Almelo Pvt. Ltd. Related Developments
• 11.6 Divi’s Laboratories Ltd.
  • 11.6.1 Divi’s Laboratories Ltd. Corporation Information
  • 11.6.2 Divi’s Laboratories Ltd. Description and Business Overview
  • 11.6.3 Divi’s Laboratories Ltd. Sales, Revenue and Gross Margin (2015-2020)
  • 11.6.4 Divi’s Laboratories Ltd. Pregabalin Products Offered
  • 11.6.5 Divi’s Laboratories Ltd. Related Developments
• 11.7 Angels Pharma India Pvt. Ltd.
  • 11.7.1 Angels Pharma India Pvt. Ltd. Corporation Information
  • 11.7.2 Angels Pharma India Pvt. Ltd. Description and Business Overview
  • 11.7.3 Angels Pharma India Pvt. Ltd. Sales, Revenue and Gross Margin (2015-2020)
  • 11.7.4 Angels Pharma India Pvt. Ltd. Pregabalin Products Offered
  • 11.7.5 Angels Pharma India Pvt. Ltd. Related Developments
• 11.8 ARITE Pharmaceutical Co., Ltd.
  • 11.8.1 ARITE Pharmaceutical Co., Ltd. Corporation Information
  • 11.8.2 ARITE Pharmaceutical Co., Ltd. Description and Business Overview
  • 11.8.3 ARITE Pharmaceutical Co., Ltd. Sales, Revenue and Gross Margin (2015-2020)
  • 11.8.4 ARITE Pharmaceutical Co., Ltd. Pregabalin Products Offered
  • 11.8.5 ARITE Pharmaceutical Co., Ltd. Related Developments
• 11.9 Bal Pharma Limited.
  • 11.9.1 Bal Pharma Limited. Corporation Information
  • 11.9.2 Bal Pharma Limited. Description and Business Overview
  • 11.9.3 Bal Pharma Limited. Sales, Revenue and Gross Margin (2015-2020)
  • 11.9.4 Bal Pharma Limited. Pregabalin Products Offered
  • 11.9.5 Bal Pharma Limited. Related Developments
• 11.10 Bazayan & Co.
  • 11.10.1 Bazayan & Co. Corporation Information
  • 11.10.2 Bazayan & Co. Description and Business Overview
  • 11.10.3 Bazayan & Co. Sales, Revenue and Gross Margin (2015-2020)
  • 11.10.4 Bazayan & Co. Pregabalin Products Offered
  • 11.10.5 Bazayan & Co. Related Developments
• 11.1 ZCL Chemicals Ltd.
  • 11.1.1 ZCL Chemicals Ltd. Corporation Information
  • 11.1.2 ZCL Chemicals Ltd. Description and Business Overview
  • 11.1.3 ZCL Chemicals Ltd. Sales, Revenue and Gross Margin (2015-2020)
  • 11.1.4 ZCL Chemicals Ltd. Pregabalin Products Offered
  • 11.1.5 ZCL Chemicals Ltd. Related Developments
• 11.12 Hikal Ltd.
  • 11.12.1 Hikal Ltd. Corporation Information
  • 11.12.2 Hikal Ltd. Description and Business Overview
  • 11.12.3 Hikal Ltd. Sales, Revenue and Gross Margin (2015-2020)
  • 11.12.4 Hikal Ltd. Products Offered
  • 11.12.5 Hikal Ltd. Related Developments
• 11.13 Glenmark Life Sciences
  • 11.13.1 Glenmark Life Sciences Corporation Information
  • 11.13.2 Glenmark Life Sciences Description and Business Overview
  • 11.13.3 Glenmark Life Sciences Sales, Revenue and Gross Margin (2015-2020)
  • 11.13.4 Glenmark Life Sciences Products Offered
  • 11.13.5 Glenmark Life Sciences Related Developments
• 11.14 Dongbang FTL
  • 11.14.1 Dongbang FTL Corporation Information
  • 11.14.2 Dongbang FTL Description and Business Overview
  • 11.14.3 Dongbang FTL Sales, Revenue and Gross Margin (2015-2020)
  • 11.14.4 Dongbang FTL Products Offered
  • 11.14.5 Dongbang FTL Related Developments
• 11.15 Teva Pharmaceutical Industries Ltd.
  • 11.15.1 Teva Pharmaceutical Industries Ltd. Corporation Information
  • 11.15.2 Teva Pharmaceutical Industries Ltd. Description and Business Overview
  • 11.15.3 Teva Pharmaceutical Industries Ltd. Sales, Revenue and Gross Margin (2015-2020)
  • 11.15.4 Teva Pharmaceutical Industries Ltd. Products Offered
  • 11.15.5 Teva Pharmaceutical Industries Ltd. Related Developments
• 11.16 Divi’s Laboratories Ltd.
  • 11.16.1 Divi’s Laboratories Ltd. Corporation Information
  • 11.16.2 Divi’s Laboratories Ltd. Description and Business Overview
  • 11.16.3 Divi’s Laboratories Ltd. Sales, Revenue and Gross Margin (2015-2020)
  • 11.16.4 Divi’s Laboratories Ltd. Products Offered
  • 11.16.5 Divi’s Laboratories Ltd. Related Developments
• 11.17 CHEMO
  • 11.17.1 CHEMO Corporation Information
  • 11.17.2 CHEMO Description and Business Overview
  • 11.17.3 CHEMO Sales, Revenue and Gross Margin (2015-2020)
  • 11.17.4 CHEMO Products Offered
  • 11.17.5 CHEMO Related Developments
• 11.18 Maps Laboratories Pvt. Ltd.
  • 11.18.1 Maps Laboratories Pvt. Ltd. Corporation Information
  • 11.18.2 Maps Laboratories Pvt. Ltd. Description and Business Overview
  • 11.18.3 Maps Laboratories Pvt. Ltd. Sales, Revenue and Gross Margin (2015-2020)
  • 11.18.4 Maps Laboratories Pvt. Ltd. Products Offered
  • 11.18.5 Maps Laboratories Pvt. Ltd. Related Developments
• 11.19 Laurus Labs
  • 11.19.1 Laurus Labs Corporation Information
  • 11.19.2 Laurus Labs Description and Business Overview
  • 11.19.3 Laurus Labs Sales, Revenue and Gross Margin (2015-2020)
  • 11.19.4 Laurus Labs Products Offered
  • 11.19.5 Laurus Labs Related Developments
• 11.20 Zhejiang Huahai Pharmaceutical Co., Ltd.
  • 11.20.1 Zhejiang Huahai Pharmaceutical Co., Ltd. Corporation Information
  • 11.20.2 Zhejiang Huahai Pharmaceutical Co., Ltd. Description and Business Overview
  • 11.20.3 Zhejiang Huahai Pharmaceutical Co., Ltd. Sales, Revenue and Gross Margin (2015-2020)
  • 11.20.4 Zhejiang Huahai Pharmaceutical Co., Ltd. Products Offered
  • 11.20.5 Zhejiang Huahai Pharmaceutical Co., Ltd. Related Developments
• 11.21 Vasudha Pharma Chem Ltd.
  • 11.21.1 Vasudha Pharma Chem Ltd. Corporation Information
  • 11.21.2 Vasudha Pharma Chem Ltd. Description and Business Overview
  • 11.21.3 Vasudha Pharma Chem Ltd. Sales, Revenue and Gross Margin (2015-2020)
  • 11.21.4 Vasudha Pharma Chem Ltd. Products Offered
  • 11.21.5 Vasudha Pharma Chem Ltd. Related Developments
• 11.22 Sun Pharmaceutical Industries Ltd.
  • 11.22.1 Sun Pharmaceutical Industries Ltd. Corporation Information
  • 11.22.2 Sun Pharmaceutical Industries Ltd. Description and Business Overview
  • 11.22.3 Sun Pharmaceutical Industries Ltd. Sales, Revenue and Gross Margin (2015-2020)
  • 11.22.4 Sun Pharmaceutical Industries Ltd. Products Offered
  • 11.22.5 Sun Pharmaceutical Industries Ltd. Related Developments
• 11.23 CTX Life Sciences Pvt. Ltd.
  • 11.23.1 CTX Life Sciences Pvt. Ltd. Corporation Information
  • 11.23.2 CTX Life Sciences Pvt. Ltd. Description and Business Overview
  • 11.23.3 CTX Life Sciences Pvt. Ltd. Sales, Revenue and Gross Margin (2015-2020)
  • 11.23.4 CTX Life Sciences Pvt. Ltd. Products Offered
  • 11.23.5 CTX Life Sciences Pvt. Ltd. Related Developments
• 11.24 Srini Pharmaceuticals Pvt. Ltd.
  • 11.24.1 Srini Pharmaceuticals Pvt. Ltd. Corporation Information
  • 11.24.2 Srini Pharmaceuticals Pvt. Ltd. Description and Business Overview
  • 11.24.3 Srini Pharmaceuticals Pvt. Ltd. Sales, Revenue and Gross Margin (2015-2020)
  • 11.24.4 Srini Pharmaceuticals Pvt. Ltd. Products Offered
  • 11.24.5 Srini Pharmaceuticals Pvt. Ltd. Related Developments

12 Future Forecast by Regions (Countries) (2021-2026)

• 12.1 Pregabalin Market Estimates and Projections by Region
  • 12.1.1 Global Pregabalin Sales Forecast by Regions 2021-2026
  • 12.1.2 Global Pregabalin Revenue Forecast by Regions 2021-2026
• 12.2 North America Pregabalin Market Size Forecast (2021-2026)
  • 12.2.1 North America: Pregabalin Sales Forecast (2021-2026)
  • 12.2.2 North America: Pregabalin Revenue Forecast (2021-2026)
  • 12.2.3 North America: Pregabalin Market Size Forecast by Country (2021-2026)
• 12.3 Europe Pregabalin Market Size Forecast (2021-2026)
  • 12.3.1 Europe: Pregabalin Sales Forecast (2021-2026)
  • 12.3.2 Europe: Pregabalin Revenue Forecast (2021-2026)
  • 12.3.3 Europe: Pregabalin Market Size Forecast by Country (2021-2026)
• 12.4 Asia Pacific Pregabalin Market Size Forecast (2021-2026)
  • 12.4.1 Asia Pacific: Pregabalin Sales Forecast (2021-2026)
  • 12.4.2 Asia Pacific: Pregabalin Revenue Forecast (2021-2026)
  • 12.4.3 Asia Pacific: Pregabalin Market Size Forecast by Region (2021-2026)
• 12.5 Latin America Pregabalin Market Size Forecast (2021-2026)
  • 12.5.1 Latin America: Pregabalin Sales Forecast (2021-2026)
  • 12.5.2 Latin America: Pregabalin Revenue Forecast (2021-2026)
  • 12.5.3 Latin America: Pregabalin Market Size Forecast by Country (2021-2026)
• 12.6 Middle East and Africa Pregabalin Market Size Forecast (2021-2026)
  • 12.6.1 Middle East and Africa: Pregabalin Sales Forecast (2021-2026)
  • 12.6.2 Middle East and Africa: Pregabalin Revenue Forecast (2021-2026)
  • 12.6.3 Middle East and Africa: Pregabalin Market Size Forecast by Country (2021-2026)

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis

• 13.1 Market Opportunities and Drivers
• 13.2 Market Challenges
• 13.3 Market Risks/Restraints
• 13.4 Porter's Five Forces Analysis
• 13.5 Primary Interviews with Key Pregabalin Players (Opinion Leaders)

14 Value Chain and Sales Channels Analysis

• 14.1 Value Chain Analysis
• 14.2 Pregabalin Customers
• 14.3 Sales Channels Analysis
  • 14.3.1 Sales Channels
  • 14.3.2 Distributors

15 Research Findings and Conclusion

16 Appendix

• 16.1 Research Methodology
  • 16.1.1 Methodology/Research Approach
  • 16.1.2 Data Source
• 16.2 Author Details